338 related articles for article (PubMed ID: 33667953)
1. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
[TBL] [Abstract][Full Text] [Related]
2. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
[TBL] [Abstract][Full Text] [Related]
3. Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury.
Kurihara K; Sasaki M; Nagahama H; Obara H; Fukushi R; Hirota R; Yoshimoto M; Teramoto A; Kocsis JD; Yamashita T; Honmou O
Brain Res; 2023 Oct; 1817():148484. PubMed ID: 37442249
[TBL] [Abstract][Full Text] [Related]
4. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
Syková E; Jendelová P; Urdzíková L; Lesný P; Hejcl A
Cell Mol Neurobiol; 2006; 26(7-8):1113-29. PubMed ID: 16633897
[TBL] [Abstract][Full Text] [Related]
6. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
[TBL] [Abstract][Full Text] [Related]
8. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.
Bydon M; Dietz AB; Goncalves S; Moinuddin FM; Alvi MA; Goyal A; Yolcu Y; Hunt CL; Garlanger KL; Del Fabro AS; Reeves RK; Terzic A; Windebank AJ; Qu W
Mayo Clin Proc; 2020 Feb; 95(2):406-414. PubMed ID: 31785831
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.
Zamani H; Soufizomorrod M; Oraee-Yazdani S; Naviafar D; Akhlaghpasand M; Seddighi A; Soleimani M
Spinal Cord; 2022 Jan; 60(1):63-70. PubMed ID: 34504283
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial.
Oka S; Yamaki T; Sasaki M; Ukai R; Takemura M; Yokoyama T; Kataoka-Sasaki Y; Onodera R; Ito YM; Kobayashi S; Kocsis JD; Iwadate Y; Honmou O
JMIR Res Protoc; 2022 Jul; 11(7):e37898. PubMed ID: 35793128
[TBL] [Abstract][Full Text] [Related]
12. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
[TBL] [Abstract][Full Text] [Related]
13. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis.
Yousefifard M; Nasseri Maleki S; Askarian-Amiri S; Vaccaro AR; Chapman JR; Fehlings MG; Hosseini M; Rahimi-Movaghar V
J Neurosurg Spine; 2019 Nov; 32(2):269-284. PubMed ID: 31675724
[TBL] [Abstract][Full Text] [Related]
14. A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury.
Oh SK; Choi KH; Yoo JY; Kim DY; Kim SJ; Jeon SR
Neurosurgery; 2016 Mar; 78(3):436-47; discussion 447. PubMed ID: 26891377
[TBL] [Abstract][Full Text] [Related]
15. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.
Xiao Z; Tang F; Zhao Y; Han G; Yin N; Li X; Chen B; Han S; Jiang X; Yun C; Zhao C; Cheng S; Zhang S; Dai J
Cell Transplant; 2018 Jun; 27(6):907-915. PubMed ID: 29871514
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.
Hur JW; Cho TH; Park DH; Lee JB; Park JY; Chung YG
J Spinal Cord Med; 2016 Nov; 39(6):655-664. PubMed ID: 26208177
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans.
Park JH; Kim DY; Sung IY; Choi GH; Jeon MH; Kim KK; Jeon SR
Neurosurgery; 2012 May; 70(5):1238-47; discussion 1247. PubMed ID: 22127044
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.
Osaka M; Honmou O; Murakami T; Nonaka T; Houkin K; Hamada H; Kocsis JD
Brain Res; 2010 Jul; 1343():226-35. PubMed ID: 20470759
[TBL] [Abstract][Full Text] [Related]
19. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
[TBL] [Abstract][Full Text] [Related]
20. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
